RxDoctor Payments Data

Johana Duque

Medical · Lauderdale Lakes, FLNPI 1497057350

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.3% of the total across 613 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,913in general payments, 2019–2025

Across 613 payments — averaging $22.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • AbbVie$2K
  • Mallinckrodt Hospital Products Inc.$1K
  • Aurinia Pharma U.S., Inc.$1K
  • AstraZeneca$960
  • UCB, Inc.$950
  • plus $6K from 33 others

What the payments were for

  • Food & beverage$13,67398%
  • Education$2392%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,913 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cimzia (2 Pack)Certolizumab Pegol61$421,835
OrenciaAbatacept/Maltose88$358,684
Humira(Cf) PenAdalimumab32$257,269
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5016$256,212
Evenity (2 Syringes)Romosozumab-Aqqg93$226,674
ProliaDenosumab104$183,105
Enbrel SureclickEtanercept24$182,645
ActemraTocilizumab35$164,449
RuxienceRituximab-Pvvr11$129,437
Simponi AriaGolimumab16$104,401
BenlystaBelimumab19$102,722
SaphneloAnifrolumab-Fnia19$96,154
TymlosAbaloparatide31$83,406
RemicadeInfliximab19$70,791
Teriparatide15$29,381

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
UCB, Inc.Cimzia (2 Pack)$950$421,83561 claims
AmgenEvenity (2 Syringes), Prolia$1,927$409,779197 claims
E.r. Squibb & Sons, L.L.C.Orencia$398$358,68488 claims
Johnson & JohnsonSimponi Aria, Remicade$757$175,19235 claims
Genentech, Inc.Actemra$19$164,44935 claims
PfizerRuxience$197$129,43711 claims
GSKBenlysta$883$102,72219 claims
AstraZenecaSaphnelo$960$96,15419 claims
Radius Health, Inc.Tymlos$574$83,40631 claims
Alvogen IncTeriparatide$200$29,38115 claims
Scilex Pharmaceuticals Inc.Colchicine$189$2,91435 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,031 medical providers in Florida.

Other medical in Lauderdale Lakes

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →